Complication    The potential impact of primary percutaneous coronary intervention on ventricular septal rupture complicating acute myocardial infarction Chest (2004);125:1622-8 H. K. Yip, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Circulation (2004);109:494-9 P. G. Steg, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention Circulation (2004);110:2837-42 K. Spargias, et al. Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions J Am Coll Cardiol (2004);44:357-61 M. Singh, et al. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization J Am Coll Cardiol (2004);44:300-4 H. Sato, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy Circulation (2004);109:1476-81 D. A. Payne, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J Am Coll Cardiol (2004);44:1780-5 G. Marenzi, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents Am J Cardiol (2005);95:167-72 P. A. Lemos, et al. Vascular complications following coronary intervention correlate with long-term cardiac events Catheter Cardiovasc Interv (2004);62:181-5 P. K. Kuchulakanti, et al. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial) Am J Cardiol (2004);93:458-61 D. E. Kandzari, et al. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature Eur Heart J (2004);25:212-8 I. Goldenberg, et al. Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures Am Heart J (2004);147:140-5 P. Fasseas, et al. Characteristics of cerebrovascular accidents after percutaneous coronary interventions J Am Coll Cardiol (2004);43:1161-7 S. Dukkipati, et al. N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity J Am Coll Cardiol (2004);44:762-5 C. Briguori, et al. Vascular access site complications with the use of closure devices in patients treated with platelet glycoprotein IIb/IIIa inhibitors during rescue angioplasty Catheter Cardiovasc Interv (2004);63:284-9 F. Boccalandro, et al. Comparison of femoral bleeding complications after coronary angiography versus percutaneous coronary intervention Am J Cardiol (2004);94:361-3 C. Berry, et al. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon J Am Coll Cardiol (2004);44:57-62 J. F. Beltrame, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification Am J Cardiol (2004);93:1515-9 B. A. Bartholomew, et al. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon Catheter Cardiovasc Interv (2004);61:484-91 C. Barcin, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med (2004);351:1285-95 N. S. Anavekar, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment J Am Coll Cardiol (2004);43:1596-601 A. Abou-Chebl, et al.